Aviva PLC Zimmer Biomet Holdings, Inc. Transaction History

Aviva PLC

$36.8 Billion
Q3 2024

A detailed history of Aviva PLC transactions in Zimmer Biomet Holdings, Inc. stock. As of the latest transaction made, Aviva PLC holds 60,267 shares of ZBH stock, worth $6.64 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

60,267

Previous 59,424 1.42%

Holding current value

$6.64 Million

Previous $6.45 Million 0.87%

% of portfolio

0.02%

Previous 0.02%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$104.47 - $116.17 $88,068 - $97,931	843 Added 1.42%	60,267 $6.51 Million
Q2 2024 Aug 02, 2024	SELL	$106.25 - $130.01 $436,793 - $534,471	-4,111 Reduced 6.47%	59,424 $6.45 Million
Q1 2024 May 14, 2024	SELL	$119.98 - $132.61 $7.17 Million - $7.92 Million	-59,721 Reduced 48.45%	63,535 $8.39 Million
Q4 2023 Feb 09, 2024	BUY	$102.72 - $121.7 $5.73 Million - $6.79 Million	55,788 Added 82.69%	123,256 $15 Million
Q3 2023 Nov 13, 2023	SELL	$110.76 - $143.18 $10.5 Million - $13.6 Million	-95,122 Reduced 58.5%	67,468 $7.57 Million
Q2 2023 Aug 10, 2023	SELL	$126.43 - $145.6 $5.68 Million - $6.54 Million	-44,925 Reduced 21.65%	162,590 $23.7 Million
Q1 2023 May 12, 2023	BUY	$121.91 - $130.94 $21.8 Million - $23.4 Million	179,057 Added 629.2%	207,515 $26.8 Million
Q4 2022 Feb 09, 2023	SELL	$104.7 - $128.4 $114,960 - $140,983	-1,098 Reduced 3.71%	28,458 $3.63 Million
Q3 2022 Nov 14, 2022	BUY	$101.65 - $119.27 $4,370 - $5,128	43 Added 0.15%	29,556 $3.09 Million
Q2 2022 Aug 04, 2022	SELL	$102.23 - $133.85 $114,804 - $150,313	-1,123 Reduced 3.67%	29,513 $3.1 Million
Q1 2022 May 13, 2022	BUY	$108.42 - $129.58 $14,853 - $17,752	137 Added 0.45%	30,636 $3.92 Million
Q4 2021 Feb 10, 2022	SELL	$115.43 - $146.63 $578,766 - $735,202	-5,014 Reduced 14.12%	30,499 $3.88 Million
Q3 2021 Nov 12, 2021	SELL	$136.35 - $158.76 $4.31 Million - $5.02 Million	-31,592 Reduced 47.08%	35,513 $5.2 Million
Q2 2021 Aug 10, 2021	SELL	$152.95 - $173.41 $247,626 - $280,750	-1,619 Reduced 2.36%	67,105 $10.8 Million
Q1 2021 May 13, 2021	BUY	$148.16 - $159.71 $72,894 - $78,577	492 Added 0.72%	68,724 $11 Million
Q4 2020 Feb 10, 2021	BUY	$128.25 - $151.41 $179,421 - $211,822	1,399 Added 2.09%	68,232 $10.5 Million
Q3 2020 Nov 12, 2020	SELL	$113.59 - $141.68 $234,563 - $292,569	-2,065 Reduced 3.0%	66,833 $9.1 Million
Q2 2020 Aug 13, 2020	BUY	$87.02 - $133.4 $1.85 Million - $2.84 Million	21,253 Added 44.61%	68,898 $8.22 Million
Q1 2020 May 14, 2020	SELL	$78.28 - $155.73 $98,084 - $195,129	-1,253 Reduced 2.56%	47,645 $4.82 Million
Q4 2019 Feb 10, 2020	SELL	$127.4 - $146.83 $287,796 - $331,688	-2,259 Reduced 4.42%	48,898 $7.32 Million
Q3 2019 Nov 12, 2019	SELL	$113.33 - $138.46 $2.73 Million - $3.33 Million	-24,083 Reduced 32.01%	51,157 $7.02 Million
Q2 2019 Jul 30, 2019	SELL	$108.87 - $125.09 $191,611 - $220,158	-1,760 Reduced 2.29%	75,240 $8.86 Million
Q1 2019 May 14, 2019	BUY	$97.5 - $125.79 $73,222 - $94,468	751 Added 0.98%	77,000 $9.83 Million
Q4 2018 Feb 12, 2019	SELL	$94.4 - $126.76 $2.16 Million - $2.89 Million	-22,834 Reduced 23.05%	76,249 $7.91 Million
Q3 2018 Nov 13, 2018	SELL	$108.41 - $127.64 $323,712 - $381,133	-2,986 Reduced 2.93%	99,083 $13 Million
Q2 2018 Aug 01, 2018	SELL	$102.12 - $114.04 $90,580 - $101,153	-887 Reduced 0.86%	102,069 $11.4 Million
Q1 2018 May 14, 2018	SELL	$104.31 - $124.46 $897,691 - $1.07 Million	-8,606 Reduced 7.71%	102,956 $11.2 Million
Q4 2017 Feb 13, 2018	SELL	$105.55 - $120.83 $1.62 Million - $1.86 Million	-15,388 Reduced 12.12%	111,562 $13.5 Million
Q3 2017 Nov 13, 2017	BUY	$106.92 - $117.79 $180,694 - $199,065	1,690 Added 1.35%	126,950 $14.9 Million
Q2 2017 Aug 07, 2017	BUY	N/A	125,260	125,260 $16.1 Million

Others Institutions Holding ZBH

# of Institutions

1,080

Shares Held

179M

Call Options Held

301K

Put Options Held

View Full List

About ZIMMER BIOMET HOLDINGS, INC.

Ticker ZBH
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 209,820,000
Market Cap $23.1B
Description
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...

More about ZBH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

News

Stay updated on Aviva PLC with notifications on news.

Account